Rosa Biotech accelerates NASH pre-clinical trial in liver disease

Rosa Biotech accelerates NASH pre-clinical trial in liver disease

Source: 
Biopharma Reporter
snippet: 

Following its latest funding round, Rosa Biotech has announced plans to accelerate development of its bio-sensing technology, designed to enable cost effective screening of a range of diseases with high accuracy at an early stage.